Results

Total Results: 1,541 records

Showing results for "months".

101. Management of Uterine Fibroids - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
     December 01, 2017 - The evidence, based on an average followup time of five months (range: 3 to 12 months), suggests the … Only six studies followed women post- treatment, for 3 to 6 months. … being 18 months. … In the 8 longer study there was no further growth between 6 and 12 months. … Overall, fewer than half of women had another intervention within 24 months.

102. Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Final Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/outcome-research-white-paper.pdf
     June 01, 2022 - months (+/- 60 days) post-index date. … Patient’s PHQ-9 total score 12 months (+/- 60 days) post-index date. … Timeframe for measurement: ● 6 months (+/- 60 days) ● 12 months (+/- 60 days) In some implementations … Timeframe for measurement: ● 6 months (+/- 60 days) ● 12 months (+/- 60 days) In some implementations … Timeframe for measurement: ● 6 months (+/- 60 days) ● 12 months (+/- 60 days) In some implementations

103. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … Median follow-up was 8 months. … : 35 months. … The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … Median follow-up was 8 months.

104. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … Median follow-up was 8 months. … : 35 months. … The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … Median follow-up was 8 months.

105. Appendix-Table-B-1-Observational-Studies (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
     March 20, 2021 - Publication Status at Time of Report Publication Link/URL Country Study Design Length of Followup (Months … Brand Definition of Reinfection Followup Test Type Frequency of Followup Testing Waiting Interval, in Months … 0.026 Abu-Raddad 2021 SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months … odds ratio: 0.09 (95% CI: 0.005–0.48) Gallais 2021 Anti-SARS-CoV-2 antibodies persist for up to 13 months … ) for positive cohort Immunoassay (Patient-reported symptoms also used in lieu of PCR) Conducted at months

106. Alcohol-Misuse Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
     April 28, 2010 - 17 percent for men and 8 percent for women;16 prevalence of current dependence (within the last 12 months … Studies of at least 6 months’ duration were eligible. … Single-question screens covering the past 12 months have reported sensitivities of 0.82 to 0.87 and … Insufficient Utilization Hospitalization Fewer hospital days in last 6 months for intervention group … compared with the control group at 6, 12, and 48 months: 35 vs. 180, 91 vs. 146, and 420 vs. 664,

107. Behavioral Programs for Type 1 Diabetes Mellitus: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
     January 01, 2016 - followup 7 1333 ↔ −0.22 (−0.49 to 0.05) ��� >12-month followup 4 1138 ↔ −0.40 (−0.92 to 0.12) (>12 months … to <24 months) ��� Behavioral program vs. active control§ HbA1c End of intervention 4 566 ↔ −0.32 … measured at ≤1 month after the intervention; the duration of the interventions ranged between 1.5 to 25.0 months … behavioral programs seemed to have some benefit in patients with T1DM for reducing HbA1c up to 6 months … to determine the effectiveness of behavioral programs for T1DM at durations of followup beyond 6 months

108. Management of Insomnia Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_consumer.pdf
     August 01, 2017 - which a person has trouble falling asleep or staying asleep, and the sleeping problem lasts at least 3 months … for people with insomnia disorder, sleep problems happen at least 3 nights each week for at least 3 months … But, these medicines are only meant to be taken for short periods of time (4 weeks to 3 months). … it takes to fall asleep, total sleep time, and how well you sleep in the short term (4 weeks to 3 months … ) and long term (longer than 3 months). »CBT-I does not appear to have side effects

109. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - , either idiopathic or neurogenic (secondary to a neurological lesion present for >12 months), … months; patients with contraindications to antimuscarinic therapy (e.g., uncontrolled narrow-angle … Dmochowski, 200824 RCT USA N: 564 Men and women aged 18 years or older with OAB of 6 months’ … Vardy, 200985 Eligible patients (aged ≥18 years) were required to have OAB symptoms for ≥3 months … Inc. and Glaxo- Smithkline Wang, 200686 Age: 16 to 80 years; OAB for more than 6 months.

110. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - that is chronic in nature, meaning the symptom has persisted for the majority of the prior three months … Population: Nonpregnant women from menarche to menopause who have had abnormal bleeding for three months …  Abnormal cyclic uterine bleeding: problem bleeding of three months or greater duration, excluding … for three months or longer. … Primary care management of abnormal uterine bleeding *Problem bleeding for 3 months or longer,

111. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - EPC Investigator Other Experts Conclusion from SCEPC adrenergic blocker, 5 percent lower at 6 months … Conclusion from SCEPC significant differences in IOP reduction between the two groups at 9-12 months … Ex-PRESS glaucoma filtration device implantation IOP or need for medications over 30 months postop … Efficacy: IOP reduction and need for medications were comparable for both procedures at 30 months … brimonidine/timolol FC 2-month timolol run in 3 months tx w/ each therapy No SAEs were reported

112. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
     October 12, 2015 - Calendar time (months) !! Number of cycles o! … 12 months or more from time of first donation •! … months!of!regular!intercourse!for!women!under!35,!or!6!months!for! women!35!and!older!(alternate! … months!of!life! if!live!birth!occurs! •! Long0term! o! 12!months!or!more!from!completion!of! … months! after!donation! •! Long0term:! o! 12!months!or!more!from!time!of!first!donation! !

113. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - – For treatment durations of 3 to 6 months (short-term), 6 to 12 months (intermediate), and ≥12 … months (long-term) … For all KQs, we included and focused on RCTs with at least 3 months’ duration. … , 6 to 12 months, and ≥12 months). … Of the good- and fair-quality trials, 128 were classified as short duration (3 months to <6 months)

114. Glasgow.Presentation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/interactive_media_glasgow_presentation.pdf
     January 01, 2009 -  Lifestyle  Program  RCT:   • Women  with  type  2  diabetes   • Initial  6  months … Correctly  Benefit   Effectiveness   3.2%   50%  Continue  to  Benefit  After  6  Months … up  includes  repeat  PCP  diabetes  visit  as  recommended  at  6  and  12  months …  activity  targets   • Follow-­‐up  includes  repeat  visit  at  2  and  12  months

115. Topic 0613 Tympanostomy Tubes NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
     November 03, 2014 - AOM is considered recurrent when children have had at least three episodes within six months or four … OME is considered chronic when it persists beyond three months.1 At any given time, 5% of children aged … Most criticism has centered on surgery in children with OME of less than three months duration determined

116. Topic 0527 Fertility Treatment in Women NSD SJ clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0623-140828.pdf
     April 25, 2014 - Infertility, which can affect both men and women, is defined as the inability to conceive after 12 months … (or in six months if a woman is older than 35 years of age).

117. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
     May 04, 2013 - by 10 db at 4-6 months post surgery and by 4 db at 6-9 months post surgery The same information was … months] to moderate [6 to 9 months] SOE”. … We noted a similar difference for hearing loss up to 6 months after tube placement. … of age had larger vocabularies when they were 18 an 24 months old than those who could not. … RCTs met the criteria for severe, persistent OME before 24 months of age.

118. Traumatic-Brain-Injury-Rehabilitation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_executive.pdf
     June 01, 2012 - 45 7 Most of the programs addressed TBI survivors whose impairments had persisted more than 6 months … However, three interventions addressed patients earlier in the postacute period, within 6 months of … 331-33 9 months 144 Note: This table briefly summarizes characteristics of the studied interventions … Median time since injury varied widely among studies, from 1 to 45 months with a median of 19 months … Two studies specifically restricted enrollees to those within 342 or 643 months of injury.

119. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in AdultsBrain Injury in Adults Surveillance Report 08082016 CCKK CC final clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
     May 29, 2025 - $Rehospitalization$During$9$Months$After$ Inpatient$Rehabilitation$for$Traumatic$Brain$Injury. … $Health"related$quality$of$life$12$months$after$severe$ traumatic$brain$injury:$a$prospective$nationwide … $ •$ Neuropsychological$rehabilitation$ o$ Outpatient$rehab$center,$24$hours/week$for$6$months$ • … $ •$ Neuropsychological$rehabilitation$ o$ Outpatient$rehab$center,$24$ hours/week$for$6$months$ … $This$study$measured$ outcomes$through$24$months,$ but,$due$to$limited$data,$the$ risk$of$bias$was

120. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
     March 01, 2021 - specific purposes (e.g., use of morphine-equivalent pain medications, non-surgical treatments) • 3 months … specific purposes (e.g., use of morphine-equivalent pain medications, non-surgical treatments) • 3 months … specific purposes (e.g., use of morphine-equivalent pain medications, non-surgical treatments) • 3 months … specific purposes (e.g., use of morphine-equivalent pain medications, non-surgical treatments) • 3 months … specific purposes (e.g., use of morphine-equivalent pain medications, non-surgical treatments) • 3 months